anyone hearing?

Based on the Phase 3 results, Keryx plans to submit a supplemental new drug application (sNDA) for approval to the U.S. FDA in the third quarter of 2016

So hectic in Boston that no one can even update a website.
 






























Rather than being acquired, Keryx announces acquisition (or merger)? (Note: random speculation)

Suspect biotech M&A is going to be rampant with lax regulatory Trump environment. Execution is key for Keryx to become a ripe candidate. Major room for improvement with a more competent leadership team. These guys haven't gotten anything right to date.
 














































































Are you kidding me...this company is still around? Haven't been on this website for close to a year? WTH? How are you all still surviving? Life must be absolute HELL here.